Avenue Therapeutics Inc (NASDAQ:ATXI) stock has tumbled to a 52-week low, touching down at $1.43, with a market capitalization of just $3.61 million. InvestingPro analysis shows the company maintains ...

Avenue Therapeutics Inc (NASDAQ:ATXI) shares are trading lower by 28.5% to $0.09 during Wednesday’s session after the company announced a reverse stock split. The company is implementing a 1-for ...

Avenue Therapeutics, Inc. (ATXI) stock price is 1.85 and Avenue Therapeutics, Inc. (ATXI) 10-day simple moving average is 1.90. Avenue Therapeutics, Inc. (ATXI) stock price is 1.85 and Avenue ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Avenue Therapeutics, Inc. (NASDAQ:ATXI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.